Summary
Adrafinil (also known as Olmifon) is a prodrug for modafinil - a wakefulness-promoting agent (eugeroic) with nootropic effects. Adrafinil is metabolized in the liver to produce modafinil. Both are stimulants with no amphetamine-like effects. Safety information on adrafinil is lacking because modafinil is often used instead, for treatment of narcolepsy and excessive daytime sleepiness. Long-term supplementation of adrafinil is not advised, since adrafinil is metabolized into modafinil in the liver, and may stress the liver through elevated liver enzymes with prolonged use.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 150-250mg | 250-400mg | 400-600mg | 600mg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects | Total |
|---|---|---|---|---|---|---|
| Oral | 45-90 min | 45-60 min | 4.5-6 hrs | 1-3 hrs | 2-6 hrs | 480-0 min |
Tolerance
Build-up
minimal; prodrug for modafinil
Reset
not well established
Cross-tolerance
Effects
Positive
- Stimulation
Negative
- Headache
- Headaches
- Increased heart rate
- Nausea
- Vasoconstriction
- Sweating
- Diarrhea
- Insomnia
- Body odor alteration
Positive
- Wakefulness
- Focus enhancement
- Motivation enhancement
- Memory enhancement
- Emotion enhancement
Negative
- Anxiety
- Irritability
- Dizziness
- Thought acceleration
- Time distortion
- Emotion intensification
- Focus intensification
Positive
- Increased music appreciation
- Increased libido
- Increased Music Appreciation
- Libido enhancement
Negative
- Appetite suppression
- Dehydration
- Photophobia
- Light sensitivity
- Appetite Suppression
- Spontaneous physical sensations